Firm once owned by 'pharma bro' Martin Shkreli to pay $40M in price-gouging settlement
December 08, 2021 at 09:14 AM EST
A company once owned by hedge fund manager Martin Shkreli, a young investor who became known as "pharma bro," has agreed to pay $40 million to settle charges that it ran up the cost for a potentially life-saving drug.